Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 27 February, 2020

Oxford Immunotec Global PLC

Oxford Immunotec to Present at the Cowen and Company 40th Annual Health Care Conference

Oxford Immunotec to Present at the Cowen and Company 40th Annual Health Care Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference on Tuesday, March 3, 2020, at 12:00 p.m. EST at the Boston Marriott Copley Place in Boston.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease.  The Company’s T-SPOT®.TB test has been approved for sale in over 60 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China.  The Company is headquartered near Oxford, U.K. and in Marlborough, MA. Additional information can be found at www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.

CONTACTS:

For Media and Investor Inquiries:
Matt McLaughlin
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
[email protected]


a d v e r t i s e m e n t